[endo2008]Prolactinomas- Some Unresolved Issues
Janet Schlechte, M.D. University of Iowa Hospitals and Clinics, Iowa City, Iowa,USA
国际糖尿病网版权所有,谢绝任何形式转载,侵犯版权者必予法律追究。

专家论述 临床科研 循证视点 endo2008 作者:JanetSchlechte,M.D. 来源:未知 2008/9/28 13:03:00    加入收藏
内容概要:A dopamine agonist is the preferred therapy for all prolactinomas and the goals of treatment are to normalize prolactin, restore gonadal function and fertility, reduce tumor size and reverse pituitary dysfunction. Despite the efficacy and widespread use of dopamine agonists, the optimal duration of therapy, outcome of drug withdrawal and the safety of long term therapy have not been established.
 延伸阅读
注册

网友评论仅供其表达个人看法,并不表明国际糖尿病同意其观点或证实其描述。 发表评论需登陆

相关标签

 
关于本站 | 设为首页 | 加入收藏 | 站长邮箱 | 友情链接 | 版权申明

国际糖尿病(www.idiabetes.com.cn)对刊载的所有文章、视频、幻灯、音频等资源拥有全部版权。未经本站许可,不得转载。

国际糖尿病 版权所有  2008-2010 idiabetes.com.cn  All Rights Reserved